The life science platform iQ spaces s taking on the development of the Berlin Center for Gene and Cell Therapies. The initiative was launched by Bayer AG and Charite – Universitätsmedizin Berlin. The project involves the construction of a modern, ten-story building with a gross floor area of c. 18,000m2 on the Bayer Campus at Nordhafen. The investment costs amount to c. €180m. Construction is scheduled to begin in 2025.
The location reflects the importance of Berlin and Germany as leading hubs for biomedical innovation and strengthens their global competitiveness in the biotechnology sector. At today's ceremony, Federal Chancellor Olaf Scholz also acknowledged the importance of the project for Germany.
The building will house an incubator with a fully equipped lab and office space, as well as customisable rental space for 15 to 20 startups at various stages of development. In addition, a production area certified to Good Manufacturing Practice (GMP) standards will be integrated.
As part of the project, iQ spaces is responsible for the acquisition of the property, the development of the translation centre and the leasing of the space. iQ spaces, a subsidiary of Rockstone Capital Partners, is part of the Rockstone Group, which is significantly involved in the realization of the project through its Berlin office.
Vincent Wege, Managing Partner of iQ spaces, said: "The development of this center for cell and gene therapies is an important milestone for Germany as a research location. We are proud to work with Bayer and Charité to create an environment that fosters innovation and bridges the gap between research and application."
The Translation Centre will be built on a prominent waterfront site in Berlin's Nordhafen district, in close proximity to Europacity, the main train station, Bayer's pharmaceutical headquarters and the Charite campus. The translation centre was designed by the architectural firm HENN, and SMV is the project manager.
Image provided by Feldhoff & Cie.
Europe Real Estate — an overview of real estate developments in European countries.
